Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral caffeine and oral ondansetron for reducing ephedrine requirement after induction of general anesthesia in elderly patients
PACTR202407794580939Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of caffeine, ondansetron and ephedrine in hypotension (3 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Intraoperative ephedrine consumption. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
caffeineondansetronephedrine
03
Conditions
hypotension
Beyond the preview
Go deeper on PACTR202407794580939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407794580939.